| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MEI Pharma, Inc. | Director | Common Stock | 1,875 | $4,106 | $2.19 | 15 Jul 2025 | Direct |
| Renovacor, Inc. | Chief Financial Officer | Option | 155,325 | 28 Mar 2022 | Direct | ||
| Cellectar Biosciences, Inc. | Director | Stock option (right to buy) | 60,000 | 14 Feb 2025 | Direct | ||
| Lite Strategy, Inc. | Director | Stock Option (Right to Buy) | 55,000 | 14 Nov 2025 | Direct | ||
| Cue Biopharma, Inc. | Director | Stock Option (right to buy) | 24,400 | 02 Jan 2025 | Direct | ||
| Flexion Therapeutics Inc | Chief Financial Officer | Common Stock | 0 | $8.50 | 19 Nov 2021 | Direct | |
| Flexion Therapeutics Inc | Chief Financial Officer | Stock option (right to buy) | 0 | 19 Nov 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LITS | Lite Strategy, Inc. | 14 Nov 2025 | 1 | $0 | 4 | Director | 18 Nov 2025, 18:36 |
| MEIP | MEI Pharma, Inc. | 15 Jul 2025 | 1 | $0 | 4 | Director | 17 Jul 2025, 21:33 |
| CLRB | Cellectar Biosciences, Inc. | 14 Feb 2025 | 1 | $0 | 4 | Director | 18 Feb 2025, 16:03 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Director | 03 Jan 2025, 16:00 |
| CLRB | Cellectar Biosciences, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 17:00 |
| CUE | Cue Biopharma, Inc. | 02 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 16:02 |
| MEIP | MEI Pharma, Inc. | 29 Sep 2023 | 1 | $0 | 4 | Director | 12 Oct 2023, 19:41 |
| CLRB | Cellectar Biosciences, Inc. | 28 Jun 2023 | 1 | $0 | 4 | Director | 28 Jun 2023, 18:24 |
| CUE | Cue Biopharma, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 15:08 |
| IVVD | Invivyd, Inc. | 13 Oct 2022 | 0 | $0 | 3 | Interim CFO | 13 Oct 2022, 16:53 |
| MEIP | MEI Pharma, Inc. | 05 Jul 2022 | 1 | $0 | 4 | Director | 07 Jul 2022, 16:27 |
| CLRB | Cellectar Biosciences, Inc. | 24 Jun 2022 | 1 | $0 | 4 | Director | 01 Aug 2022, 18:00 |
| RCOR | Renovacor, Inc. | 28 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 28 Mar 2022, 19:38 |
| RCOR | Renovacor, Inc. | 28 Mar 2022 | 0 | $0 | 3 | Chief Financial Officer | 28 Mar 2022, 19:37 |
| CUE | Cue Biopharma, Inc. | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 19:22 |
| FLXN | Flexion Therapeutics Inc | 19 Nov 2021 | 2 | -$260,780 | 4 | Chief Financial Officer | 19 Nov 2021, 09:00 |
| CLRB | Cellectar Biosciences, Inc. | 03 Sep 2021 | 1 | +$20,244 | 4 | Director | 07 Sep 2021, 16:01 |
| MEIP | MEI Pharma, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 06 Jul 2021, 18:58 |
| CLRB | Cellectar Biosciences, Inc. | 30 Jun 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 16:03 |
| FLXN | Flexion Therapeutics Inc | 01 Jun 2021 | 2 | $0 | 4 | Chief Financial Officer | 03 Jun 2021, 16:20 |
| FLXN | Flexion Therapeutics Inc | 01 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 03 Jun 2021, 16:14 |